Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective.

Objective: To evaluate the cost of lost productivity in the workplace due to allergic rhinitis compared to other selected medical conditions from an employer perspective.

Setting And Participants: A total of 8267 US employees at 47 employer locations who volunteered to participate in health/wellness screenings.

Measurements: The Work Productivity Short Inventory was used to assess the impact of a predefined group of health conditions on workplace productivity for the previous 12 months.

Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.

Study Objectives: Using data from a published clinical trial, our objectives were to compare the cost advantage of voriconazole over amphotericin B deoxycholate (AmBd) for primary treatment of invasive aspergillosis and to determine the financial impact the findings would have in a real-world clinical setting.

Design: Pharmacoeconomic analysis.

Setting: University hospital.